Dudukina, Elena http://orcid.org/0000-0002-4238-049X
Szépligeti, Szimonetta Komjáthiné
Karlsson, Pär http://orcid.org/0000-0002-7177-1713
Asomaning, Kofi
Daltveit, Anne Kjersti
Hakkarainen, Katja
Hoti, Fabian http://orcid.org/0000-0002-7464-3549
Kieler, Helle http://orcid.org/0000-0001-9338-7133
Lunde, Astrid
Odsbu, Ingvild http://orcid.org/0000-0002-5337-8619
Rantanen, Matti
Reutfors, Johan http://orcid.org/0000-0003-1372-4262
Saarelainen, Laura http://orcid.org/0000-0003-2542-8137
Ehrenstein, Vera http://orcid.org/0000-0002-3415-3254
Toft, Gunnar http://orcid.org/0000-0002-7542-6853
Funding for this research was provided by:
Pfizer (The study was funded by Pfizer Ltd through institutional research funding to and, administered by Aarhus University.)
Royal Danish Library, Aarhus University Library
Article History
Accepted: 5 April 2023
First Online: 26 April 2023
Statements and Declarations
:
: The study was funded by Pfizer Ltd through institutional research funding to and administered by Aarhus University. EPID Research Oy part of IQVIA was responsible for the study conducted in Finland funded by Pfizer Inc. through an Outcomes Research Services Agreement.
: The funder contributed to the design of the study, the interpretation, reporting of results, or writing of the manuscript. All final decisions were made by the principal investigator.
: The study received all required approvals or was reported to the national data authority according to local requirements of the participating Nordic countries. This study was reported to the Danish Data Protection Agency [CitationRef removed] through registration at Aarhus University (record number 2016-051-000001, sequential number 544). In Finland, the study received approval by Ethics Committee of the Hospital District of Helsinki and Uusimaa (HUS/887/2018). In Norway, the study received approval by Regional Committee for Medical and Health Research Ethics (2017/1507/REK vest) and by the Norwegian Data Protection Authority (17/01659-2/CDG). In Sweden, the study received approval by the Regional Ethical Review Board in Stockholm (reference numbers 2015/1826-31/2, 2017/2238-32, and 2018/1790-32).
: Not applicable.
: Not applicable.
: In the four Nordic countries participating in this study, the pseudonymized data were stored on and accessed via secure servers. For legal reasons and to protect individuals whose data were analyzed, the datasets used in this study will not be made public.
: The code producing the datasets used in this study will not be made public to protect potential individual-level data.
: All authors contributed substantially to the study’s conception, design, and interpretation of results, and critically revised the manuscript for intellectual content. GT, VE, KA, AKD, KH, FH, HK, IO, JR, and LS conceptualized the study. SKS, MR, AL, and PK analyzed the data. ED and GT drafted the manuscript. All authors read and approved the final manuscript for submission.